Literature DB >> 6327936

Light microscopic autoradiographic localization of mu and delta opioid binding sites in the mouse central nervous system.

A S Moskowitz, R R Goodman.   

Abstract

Much work has been done on opioid systems in the rat CNS. Although the mouse is widely used in pharmacological studies of opioid action, little has been done to characterize opioid systems in this species. In the present study the distribution of mu and delta opioid binding sites in the mouse CNS was examined using a quantitative in vitro autoradiography procedure. Tritiated dihydromorphine was used to visualize mu sites and [3H-d-Ala2-d-Leu5]enkephalin with a low concentration of morphine was used to visualize delta sites. Mu and delta site localizations in the mouse are very similar to those previously described in the rat ( Goodman , R.R., S.H. Snyder, M.J. Kuhar , and W.S. Young, 3d (1980) Proc. Natl. Acad. Sci. U.S.A. 77:6239-6243), with certain exceptions and additions. Mu and delta sites were observed in sensory processing areas, limbic system, extrapyramidal motor system, and cranial parasympathetic system. Differential distributions of mu and delta sites were noted in many areas. Mu sites were prominent in laminae I, IV, and VI of the neocortex, in patches in the striatum, and in the ventral pallidum, nucleus accumbens, medial and midline thalamic nuclei, medial habenular nucleus, interpeduncular nucleus, and laminae I and II of the spinal cord. In contrast, delta sites were prominent in all laminae of the neocortex, olfactory tubercle, diffusely throughout the striatum, and in the basal, lateral, and cortical nuclei of the amygdala. The determination of the differential distributions of opioid binding sites should prove useful in suggesting anatomical substrates for the actions of opiates and opioids.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327936      PMCID: PMC6564939     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  23 in total

Review 1.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

2.  Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.

Authors:  V Daugé; P Rossignol; B P Roques
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Interaction between δ opioid receptors and benzodiazepines in CO₂-induced respiratory responses in mice.

Authors:  Anne H Borkowski; Dylan C Barnes; Derek R Blanchette; F Xavier Castellanos; Donald F Klein; Donald A Wilson
Journal:  Brain Res       Date:  2011-04-28       Impact factor: 3.252

Review 4.  Opioid receptor trafficking and interaction in nociceptors.

Authors:  X Zhang; L Bao; S Li
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

5.  The laminar distribution of neuritic plaques in the fascia dentata of patients with Alzheimer's disease.

Authors:  B J Crain; P C Burger
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 6.  Supraspinal morphine and descending inhibitions acting on the dorsal horn of the rat.

Authors:  A H Dickenson; D Le Bars
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

Review 7.  Ventral pallidum roles in reward and motivation.

Authors:  Kyle S Smith; Amy J Tindell; J Wayne Aldridge; Kent C Berridge
Journal:  Behav Brain Res       Date:  2008-10-08       Impact factor: 3.332

8.  Mu-opioid receptors selectively regulate basal inhibitory transmission in the central amygdala: lack of ethanol interactions.

Authors:  Maeng-Hee Kang-Park; Brigitte L Kieffer; Amanda J Roberts; Marisa Roberto; Samuel G Madamba; George Robert Siggins; Scott D Moore
Journal:  J Pharmacol Exp Ther       Date:  2008-10-14       Impact factor: 4.030

9.  Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling.

Authors:  Pilar Sánchez-Blázquez; María Rodríguez-Muñoz; Javier Garzón
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

10.  Opioid and GABA modulation of accumbens-evoked ventral pallidal activity.

Authors:  J J Chrobak; T C Napier
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.